Thermo Fisher Scientific Inc. (NYSE:TMO) (“Thermo Fisher”) announced today that it has priced an offering of $2.5 billion aggregate principal amount (the “Offering”) of the following notes:
- $1.0 billion aggregate principal amount of its 5.000% senior notes due 2026 (the “2026 notes”), at the issue price of 99.931% of their principal amount;
- $1.0 billion aggregate principal amount of its 5.000% senior notes due 2029 (the “2029 notes”), at the issue price of 99.772% of their principal amount; and
- $500 million aggregate principal amount of its 5.200% senior notes due 2034 (the “2034 notes” and, together with the 2026 notes and the 2029 notes, the “notes”), at the issue price of 99.846% of their principal amount.
The Offering is expected to close on or about December 5, 2023, subject to the satisfaction of customary closing conditions. The notes will pay interest on a semi-annual basis.